Fulgent Data: Uncovering Fid-007 in Head and Neck Cance
Fulgent Pharma, a subsidiary of Fulgent Genetics, presented data at ASCO 2024 showing promising results for their therapeutic candidate,...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Authority FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Protocol Design Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Fulgent Pharma, a subsidiary of Fulgent Genetics, presented data at ASCO 2024 showing promising results for their therapeutic candidate,...
Neurogene Inc.’s NGN-401 gene therapy for Rett syndrome has been selected for the FDA’s Support for Clinical Trials Advancing...
Calidi Biotherapeutics presented its latest developments in antitumor virotherapy at the American Society of Clinical Oncology (ASCO) Annual Meeting....
A Phase 2b trial has demonstrated significant improvements for TAK-861, an investigational treatment for narcolepsy type 1 (NT1). The...
Summit Therapeutics raised $200 million through an institutional investment, with shares sold at a premium to the previous closing...
Thermo Fisher Scientific’s new facility in Bleiswijk, Netherlands, offers comprehensive cold and ultra-cold storage services for clinical trials and...
A 2024 DIA Europe Conference session led by Peter Richard Arlett, MD, Head of the Data Analytics and Methods...
Regulatory reliance in regulatory frameworks refers to the practice where regulatory authorities use assessments conducted by other agencies to...
Technological advancements have become indispensable in clinical data management in the rapidly evolving clinical trials industry, especially in the...
Incyte has strengthened its Inflammation and Autoimmunity pipeline by acquiring Escient Pharmaceuticals. The acquisition brings EP262 and EP547, two...